Beta Bionics (BBNX) vs vVARDIS (VVVV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
vVARDIS is the larger company by market cap ($770.9 million vs $726.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | VVVV |
|---|---|---|
| Share price | $13.36 | $14.55 |
| Market cap | $726.34M | $770.91M |
| 1-day change | +0.30% | -3.00% |
| YTD return | -56.15% | — |
| 1-year return | -57.48% | — |
| EPS (TTM) | $-1.83 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $100.25M | — |
| Revenue growth (YoY) | +53.94% | — |
| Net income (latest FY) | $-73.20M | — |
| Gross margin | 55.40% | — |
| Operating margin | -71.50% | — |
| Net margin | -73.02% | — |
| 52-week high | $32.71 | $16.95 |
| 52-week low | $8.80 | $14.00 |
| Distance from 52-week high | -59.16% | -14.16% |
| Analyst consensus | buy | — |
| Avg. price target upside | +87.87% | — |
| Average volume | 1.21M | 963.08K |
| Shares outstanding | 54.37M | 38.59M |
| Employees | 420 | 153 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Health Care · Medical/Dental Instruments · 420 employees
About vVARDIS
VVVV stock →vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.
Health Care · Medical/Dental Instruments · 153 employees
BBNX vs VVVV FAQ
Which is bigger, Beta Bionics or vVARDIS?
vVARDIS (VVVV) is larger, with a market capitalization of $770.91M compared with $726.34M for Beta Bionics (BBNX).
Are Beta Bionics and vVARDIS in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.